• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,186.87 1.44
( 0.00%)
Global Indices
Nasdaq
52,569.33 -110.31
(-0.21%)
Dow Jones
7,555.54 -37.86
(-0.50%)
Hang Seng
66,873.37 -1,878.14
(-2.73%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.14 0.39
(0.40%)
EUR-INR
109.70 0.52
(0.48%)
GBP-INR
128.61 0.54
(0.42%)
JPY-INR
0.59 0.00
(0.41%)

EQUITY - MARKET SCREENER

Aptus Pharma Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
544529
INE15XJ01010
11.6537026
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
427.64
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

bosch ltd
NBCC (India) bags Rs 131-crore construction orders
May 14,2026
The company received its first order from Central Bank of India for the construction of the bank’s office building at Amravati, Andhra Pradesh. The project will be executed under the Project Management Consultancy (PMC) model and is valued at Rs 25.52 crore. The execution timeline was not disclosed.

The second order was awarded by the Resident Commissioner, Government of Andhra Pradesh, for the construction of the new Andhra Pradesh Bhavan in New Delhi. The project, also under the PMC model, is valued at Rs 105.50 crore. The execution timeline was not disclosed.

NBCC (India) operates in three major segments—project management consultancy, real estate, and engineering procurement & construction.

The company's consolidated net profit advanced 38.5% to Rs 197.22 crore on a 7.6% rise in revenue from operations to Rs 3,022.39 crore in Q3 FY26 over Q3 FY25.

The counter shed 0.92% to Rs 94 on the BSE.